Formononetin
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Formononetin
- DrugBank Accession Number
- DB15335
- Background
Formononetin is under investigation in clinical trial NCT02174666 (Isoflavone Treatment for Postmenopausal Osteopenia.).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 268.268
Monoisotopic: 268.073558866 - Chemical Formula
- C16H12O4
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbciximab Formononetin may decrease the anticoagulant activities of Abciximab. Aceclofenac Aceclofenac may increase the thrombogenic activities of Formononetin. Acenocoumarol Formononetin may decrease the anticoagulant activities of Acenocoumarol. Acetohexamide The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Formononetin. Adalimumab Formononetin may increase the thrombogenic activities of Adalimumab. - Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 295DQC67BJ
- CAS number
- 485-72-3
- InChI Key
- HKQYGTCOTHHOMP-UHFFFAOYSA-N
- InChI
- InChI=1S/C16H12O4/c1-19-12-5-2-10(3-6-12)14-9-20-15-8-11(17)4-7-13(15)16(14)18/h2-9,17H,1H3
- IUPAC Name
- 7-hydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one
- SMILES
- COC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0005808
- KEGG Compound
- C00858
- ChemSpider
- 4444070
- BindingDB
- 50021398
- ChEBI
- 18088
- ChEMBL
- CHEMBL242341
- ZINC
- ZINC000018847036
- Wikipedia
- Formononetin
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0402 mg/mL ALOGPS logP 3.56 ALOGPS logP 2.88 Chemaxon logS -3.8 ALOGPS pKa (Strongest Acidic) 6.48 Chemaxon pKa (Strongest Basic) -4.7 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 55.76 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 74.18 m3·mol-1 Chemaxon Polarizability 27.86 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 174.7223033 predictedDarkChem Lite v0.1.0 [M-H]- 174.3621033 predictedDarkChem Lite v0.1.0 [M-H]- 163.2450692 predictedDarkChem Lite v0.1.0 [M-H]- 174.8303033 predictedDarkChem Lite v0.1.0 [M-H]- 174.5755033 predictedDarkChem Lite v0.1.0 [M-H]- 164.14003 predictedDeepCCS 1.0 (2019) [M+H]+ 175.1553033 predictedDarkChem Lite v0.1.0 [M+H]+ 175.4210033 predictedDarkChem Lite v0.1.0 [M+H]+ 172.2050733 predictedDarkChem Lite v0.1.0 [M+H]+ 175.9303033 predictedDarkChem Lite v0.1.0 [M+H]+ 178.5418033 predictedDarkChem Lite v0.1.0 [M+H]+ 166.49805 predictedDeepCCS 1.0 (2019) [M+Na]+ 174.7247033 predictedDarkChem Lite v0.1.0 [M+Na]+ 171.3009703 predictedDarkChem Standard v0.1.0 [M+Na]+ 171.4683432 predictedDarkChem Lite v0.1.0 [M+Na]+ 174.4573033 predictedDarkChem Lite v0.1.0 [M+Na]+ 174.6111033 predictedDarkChem Lite v0.1.0 [M+Na]+ 172.59119 predictedDeepCCS 1.0 (2019)
Drug created at May 20, 2019 15:16 / Updated at June 12, 2020 16:53